News for Artelo Biosciences, Inc. (ARTL)

Several companies in the biotech sector are witnessing a notable increase in search activity, as observed by InvestingChannel. Among them, Third Harmonic Bio (T

Artelo Biosciences is poised for groundbreaking advancements in its pharmaceutical pipeline. Key compounds ART26.12 and ART27.13 are central to its stra

**media[581364]**

Multiple Clinical Readouts Due in 2025 SOLANA BEACH, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( ARTL), a clinical-stage pharmaceu

**media[540854]**

SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-

Phase 1 data from the CAReS trial showed an attractive safety profile and promising activity from daily ART27.13 administration with two-thirds of participants

Artelo Biosciences, Inc. (ARTL) experienced a significant stock price increase of 5%, reaching $1.16 per share. The trading volume was 68,784 shares with a turn

Artelo Biosciences, Inc. (ARTL), a biopharmaceutical company focused on lipid signaling pathway therapies, experienced a 5.45% drop in its stock price. The shar

Artelo Biosciences, Inc. (ARTL), a biopharmaceutical company, experienced a significant stock price increase of 6.31%. The stock is currently trading at $1.18 p

SOLANA BEACH, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit

Artelo Biosciences, Inc. (ARTL) experienced a significant drop in its stock price, falling 5.39% to $1.15 with a trading volume of 18,680 shares and a turnover

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's Preclinical Screening Platform for Pain Program

These stocks are making interesting moves on high volume. Active Stocks Moving Up Today QuickLogic Corporation (QUIK) < (QUIK) is currently trading at $6....

According to Straits Research, “The global cancer cachexia market size was worth USD 2.47 billion in 2022, and it is estimated to reach an expected value...

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.00 A.M. ET)..

Read Reviewing International Stem Cell (OTCMKTS:ISCO) & Artelo Biosciences (NASDAQ:ARTL) at ETF Daily News

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...